Evidence map›Paper›PMID 42073580›Full record

ArticleCancers2026

Factors Associated with Time to Sarcoma Diagnosis: Results from a Global Cross-Sectional Survey by the Sarcoma Patient Advocacy Global Network (SPAGN).

Verena Loidl, Kathrin Schuster, Roger Wilson, Denise K Reinke, Ornella Gonzato, Matthew Sha, Lauren Pretorius, Vandana Gupta, Gerard Van Oortmerssen, Bernd Kasper

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Verena LoidlSarcoma Patient Advocacy Global Network (SPAGN), 61200 Woelfersheim, Germany.
Kathrin SchusterSarcoma Patient Advocacy Global Network (SPAGN), 61200 Woelfersheim, Germany.ORCID 0000-0002-3120-5207
Roger WilsonSarcoma Patient Advocacy Global Network (SPAGN), 61200 Woelfersheim, Germany.ORCID 0000-0002-6043-7306
Denise K ReinkeSarcoma Patient Advocacy Global Network (SPAGN), 61200 Woelfersheim, Germany.ORCID 0000-0002-8662-7060
Ornella GonzatoSarcoma Patient Advocacy Global Network (SPAGN), 61200 Woelfersheim, Germany.ORCID 0000-0002-6541-1228
Matthew ShaFaculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.ORCID 0000-0003-2845-0874
Lauren PretoriusCampaigning for Cancer, Craighall, Johannesburg 2196, South Africa.
Vandana GuptaSarcoma Patient Advocacy Global Network (SPAGN), 61200 Woelfersheim, Germany.
Gerard Van OortmerssenSarcoma Patient Advocacy Global Network (SPAGN), 61200 Woelfersheim, Germany.
Bernd KasperMannheim Cancer Center, Mannheim University Medical Center, University of Heidelberg, 68167 Mannheim, Germany.ORCID 0000-0001-8425-8356

Funding

PROJECT 3: Applying Liquid Biopsy Technologies to Detect Clinical Response and Mechanisms of Resistance in the Treatment of LMSP50CA272170 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Elizabeth Demicco · 2022 to 2026
$13.3M
NCI NIH HHS P50 CA272170
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer diagnosiscare intervaldiagnostic intervaldiagnostic pathwaymisdiagnosispatient intervalreferral pathwaysarcomasarcoma diagnosistime to diagnosis

Identifiers

PMID42073580
PMCPMC13115386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.